Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Javier Marco-Sanz
Observed names:
J Marco-Sanz,
Javier Marco-Sainz
Institutions:
Navarre Institute of Health Research,
Clinica Universidad de Navarra
Observed institutions:
Navarre Institute of Health Research,
Clinica Universidad de Navarra,
Centro de Investigación Médica Aplicada,
Universidad de Navarra
ORCID:
0000-0001-8722-0265
Observed ORCID:
0000-0001-8722-0265
OpenAlex ID:
A5059741602
Exploiting 4-1BB immune checkpoint to enhance the efficacy of oncolytic virotherapy for diffuse intrinsic pontine gliomas
2022
·
Virginia Laspidea
, Montserrat Puigdelloses
, et al.
·
JCI Insight
·
24
The oncolytic adenovirus Delta-24-RGD in combination with ONC201 induces a potent antitumor response in pediatric high-grade and diffuse midline glioma models
2024
·
Daniel de la Nava
, Iker Ausejo-Mauleon
, et al.
·
Neuro-Oncology
·
16
PDF
Combination of locoregional radiotherapy with a TIM-3 aptamer improves survival in diffuse midline glioma models
2024
·
Iker Ausejo-Mauleon
, Naiara Martinez-Velez
, et al.
·
JCI Insight
·
12
PDF
Targeting the CD40 costimulatory receptor to improve virotherapy efficacy in diffuse midline gliomas
2025
·
Sara Labiano
, Javier Marco-Sanz
, et al.
·
Cell Reports Medicine
·
10
Galectin-3 inhibition boosts the therapeutic efficacy of Semliki Forest virus in pediatric osteosarcoma
2022
·
Guillermo Herrador-Cañete
, Marta Zalacain
, et al.
·
Molecular Therapy — Oncolytics
·
8
PDF
Set Protein Is Involved in FLT3 Membrane Trafficking
2023
·
Nerea Marcotegui
, Silvia Romero-Murillo
, et al.
·
Cancers
·
6
PDF
Radiotherapy protocols for mouse cancer model
2024
·
Eneko Garate-Soraluze
, Javier Marco-Sanz
, et al.
·
Methods in cell biology
·
3
Radiotherapy synergizes with an inducible AAV-based immunotherapy platform to program local and systemic antitumor immunity
2026
·
Sonia Marco
, Myriam Fernández
, et al.
·
Cancer Cell
·
1
Dipg-04. Tumor Cell-intrinsic Tim-3 Promotes Diffuse Intrinsic Pontine Glioma Tumorigenesis
2023
·
Iker Ausejo-Mauleon
, Virginia Laspidea
, et al.
·
Neuro-Oncology
·
1
PDF
745 Oncolytic adenovirus expressing 4-1BBL demonstrates a significant increase of survival in Diffuse Midline Glioma models
2021
·
Virginia Laspidea
, Sara Labiano
, et al.
·
Journal for ImmunoTherapy of Cancer
·
1
PDF
Js07.5.a Therapeutic Tim-3 Inhibition Supports Neurological Function Post-tumor Clearance in Dmg Preclinical Models
2025
·
S Morales-Sánchez
, I Ausejo-Mauleon
, et al.
·
Neuro-Oncology
PDF
P06.11.a Conventional Type 1 Dendritic Cells Enhance Neuroprotection in Pediatric Brain Tumor Radiotherapy
2025
·
J Marco-Sanz
, A Lacalle
, et al.
·
Neuro-Oncology
PDF
DMG-17. The combination of Delta-24-RGD and TIM-3 blockade enhances oncolytic virotherapy in diffuse midline glioma.
2025
·
Sara Nuin
, Iker Ausejo-Mauleón
, et al.
·
Neuro-Oncology Pediatrics
DMG-21. Improving oncolytic virotherapy by blocking CD47- SIRPα axis with single-domain antibodies in diffuse midline gliomas
2025
·
Daniel Palacios-Alonso
, Sara Nuin
, et al.
·
Neuro-Oncology Pediatrics
DMG-42. Development of a novel spinal cord diffuse midline glioma model unveils its immune microenvironment and potential therapeutic strategies
2025
·
Reyes Hernández Osuna
, Andrea Lacalle
, et al.
·
Neuro-Oncology Pediatrics
DMG-13. Cognitive and motor effects of TIM-3 blockade in diffuse midline glioma murine models
2025
·
Sandra Morales-Sánchez
, Iker Ausejo-Mauleon
, et al.
·
Neuro-Oncology Pediatrics
Tmod-07. Development and Characterization of a Spinal Cord Diffuse Midline Glioma Model
2024
·
Reyes Hernandez-Osuna
, Andrea Lacalle
, et al.
·
Neuro-Oncology
PDF
Dipg-10. Delta-24-rgdox Promotes Antitumor Immune Response in Dmg Models
2023
·
Virginia Laspidea
, Iker Ausejo-Mauleon
, et al.
·
Neuro-Oncology
PDF
836 Activating the antigen presenting cells to improve virotherapy efficacy in diffuse midline gliomas
2022
·
Sara Labiano
, Reyes Hernández-Osuna
, et al.
·
Journal for ImmunoTherapy of Cancer
PDF
Exth-58. Unraveling the Mechanisms Underlying the Therapeutic Efficacy of Tim-3 Blockade in Dipgs
2022
·
Iker Ausejo-Mauleon
, Sara Labiano
, et al.
·
Neuro-Oncology
PDF
Abstract 2001: Delta-24-RGDOX oncolytic adenovirus improves the survival by modulating the immune system in DMG models
2022
·
Virginia Laspidea
, Sara Labiano
, et al.
·
Cancer Research
Abstract 2000: The adenovirus Delta-24-RGD in combination with ONC201 provides a therapeutic benefit and a proinflammatory recruitment in preclinical models of pHGGs and DMGs
2022
·
Daniel de la Nava
, Javier Marco-Sanz
, et al.
·
Cancer Research
IMMU-18. Targeting Antigen Presenting Cells to improve virotherapy efficacy in Diffuse Midline Gliomas
2022
·
Sara Labiano
, Javier Marco-Sanz
, et al.
·
Neuro-Oncology
PDF
Show more works
View as search
Works count:
23
Citation count:
82
H-index:
6
I10-index:
4
Year
Topic
Type